 septic complications three-drug sequential immunosuppression cadaver renal transplants renal transplant recipients results immunosuppression three-drug sequential Minnesota globulin prednisone azathioprine cyclosporine immunosuppression two-drug sequential protocol Minnesota globulin prednisone cyclosporine azathioprine study groups comparable age sex etiology renal failure incidence diabetes degree HLA Patient survival year different groups drug drug One-year graft survival superior two-drug group drug drug Analysis primary transplants results first year serum creatinine level stable groups three-drug therapy group bacterial viral infections low-risk primary cadaveric renal transplants two-drug sequential immunosuppression superior